Serhii Pelishenko/LinkedIn
Jul 19, 2026, 03:53
Serhii Pelishenko: Current Evidence on Kaolin and Chitosan Dressings
Serhii Pelishenko, Tactical Medicine Instructor and Medical Service Officer at Armed Forces of Ukraine, shared a post on LinkedIn:
“Kaolin or Chitosan?
This is one of the most common questions during TCCC and CLS training.
I decided to summarize the available evidence, explain how both hemostatic dressings work, review the current 2024 TCCC recommendations, and discuss why there is still no universal winner.
If you’re interested in evidence-based hemorrhage control, I hope you’ll find it useful.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 03:28Katrina Snow: Learning More About Sickle Cell Disease This September
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:14Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell